Latest Regulatory News

Challenger has reported a robust FY25 performance, with normalised net profit after tax rising 9% to $456 million and return on equity exceeding targets. The company’s strategic focus on annuities and digital transformation positions it well for continued growth in FY26.

Challenger Limited reported a 9% increase in normalised net profit after tax for FY25, driven by strong Life business cash earnings and resilient Funds Management performance despite net outflows. The company also announced an 11% dividend increase and provided positive FY26 EPS guidance amid ongoing regulatory reforms.

Challenger Limited reported a solid 9% rise in normalised NPAT to $456 million for FY25, alongside an 11% dividend increase to 29.5 cents per share, underscoring its strategic momentum and capital strength. The company’s outlook for FY26 remains positive, with guidance pointing to continued growth and shareholder returns amid evolving retirement income reforms.

Challenger Limited reported a robust FY25 with a 9% rise in normalised profit and a strategic push into digital transformation and retirement income solutions.

HUB24 Limited has announced a fully franked ordinary dividend of AUD 0.32 per share for the six months ending June 2025, signaling steady shareholder returns ahead of the payment date in October.

HUB24 Limited reported robust FY25 results with revenue climbing 24% to $406.6 million and underlying net profit after tax soaring 44%. The company’s platform funds under administration grew 34%, underpinning a 47% increase in fully franked dividends.

CSL Limited reported solid FY25 financials with 5% revenue growth and announced a strategic transformation including a $500 million annual cost saving target and plans to spin off its vaccine business, CSL Seqirus, as a separate ASX-listed entity.

CSL Limited posted a 14% rise in net profit for FY2025, underpinned by strong immunoglobulin sales and new product launches, while announcing plans to demerge its vaccines business, CSL Seqirus, to sharpen strategic focus.

Kaili Resources addresses ASX price query following a dramatic surge in its share price and trading volume, attributing the movement to its recent rare earth element drilling approval in South Australia.

Platinum Asia Investments Limited (PAI) shares have been suspended following Federal Court approval of a scheme exchanging all shares for units in the Platinum Asia Fund Complex ETF (PAXX). This marks a significant structural shift for PAI investors.

The Takeovers Panel has declined to intervene in the ongoing takeover tussle for PointsBet Holdings, allowing shareholders to weigh competing offers from MIXI Australia and betr Entertainment.

MAC Copper has secured Foreign Investment Review Board approval, satisfying all regulatory conditions for its acquisition by Harmony Gold’s Australian subsidiary. The deal now awaits shareholder votes and court sanction to proceed.